Intracardiac  injection of Cyclic helix B  peptide(CHBP) protects against cardiac hypertrophy and fibrosis: Intracardiac  injection of Cyclic helix B  peptide(CHBP), a peptide derived from Erythropoietin/Hematopoietin, decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1, and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via upregulation of its target gene, 1/April/2019, 11.33pm